Wiley-Ahimsa & Compassion in Jainism [Studies in Jaina Hist. & Cult.] (2006)
Point-of-Care Diagnostics - Ahimsa Fund€¦ · Improving access to healthcare using innovative...
Transcript of Point-of-Care Diagnostics - Ahimsa Fund€¦ · Improving access to healthcare using innovative...
Improving access to healthcare using innovative models
Point-of-Care Diagnostics
in
LMICs
Borderless Gold
Blended Value
Enterprise Value Social Value
Bill & Melinda Gates Foundation: approx $500 million grant
Price < $1
Bottom of the Pyramid = 4 billion people Average population in LMICs = 47,081,632 0.83 doctors/1000 individuals 6% of GDP spent on health
Lack of manufacturing & product information
IP has country-specific implications
Partnership with Oxfam - Unwrapped campaign £2.7 million in 2010 (UK) 750 shops in the UK 15,000 shops worldwide POCD can be sold for £20 ($31.17)
IDEALLY: Unprotected
Fully available
RISK:
Abuse Complicated
patent systems
PROTECTED
PATENT
Safeguard
Quality
Ownership
Profitability
GATES FOUNDATION -Financial resources -Social mindset -Prevent abuse
PRODUCERS -Lower cost -Confidentiality -Specific license
commissions
Licensing contract
Main concerns for production location: • factor costs • tax benefits • broader issues of productivity and quality • convenience for shipping to other countries • extent of political risk • social and ethical standards of suppliers • Export/import restrictions
Partnership with NGOs & SHGs
- SHGs and NGOs have established kiosks in remote communities - Responsibilities: Education + Record-keeping - Strong relationships with community helps product penetration; build trust
- High collaboration with Ahimsa/Gates foundation in the initiative
- Will also promote Lifebuoy products to ensure hygiene
Partnership with Micro-insurance
- 25%/75% partnership with the micro-insurance partners. (25% of revenues for Ahimsa) - Insurance package much more attractive POCD - Micro-insurance will gain more customers
- Ahimsa is entitled to only those customers who have been validated to have used the product
- SHGs and NGOs will assist the process of record-keeping and reporting
- 23 Micro-insurers in India to choose from (source: Indian Gov´t)
Partnership with Lifebuoy
-Lifebuoy have been targeting BOP since early 1900s
- Emphasis on educating benefits of hygiene (special convoys; campaigns)
- CSR in-line with Ahimsa’s goals
- Leverage goodwill working with Gates Foundation Improve image in 1st World (Unilever)
- Consumers relate health benefits of Lifebuoy soap to POCD benefits
- Profit of SHGs and NGOs promoting lifebuoy Increase Sales
REVENUE GENERATION Micro-insurance NGOs & SHGs
DISTRIBUTION
Lifebuoy
ADVOCACY + All partners involved
+ Rural Knowledge Centers + Micro-finance
+ Oxfam in the 1st World
Pricing IP Manufacturing Distribution Advocacy
Price too high
Compliance of producers
Quality issues Effectiveness of distributors
Education of agents
Negotiations with Micro-Insurance
Very complex country-specific issues
Location Durability of partnership contracts
Effectiveness of channels
Unstable economices
B&MGF cooperation
Durability of contracts
Poor infrastructure
Encoding & decoding
Financial exercise - India
2012
Sales 6,000,000
FAMILY COVERED 1,000,000
Revenue For POCD 25% 1,500,000
COST TOTAL 106,500,000
Labor 500,000
Manufacture&Components 6,000,000
R&D 100,000,000
Operating Profit -105,000,000
Financial exercise - India
2012 2013 2014 2015 2016
Sales 6,000,000 12,000,000 24,000,000 36,000,000 48,000,000
FAMILY COVERED 1,000,000 2,000,000 4,000,000 6,000,000 8,000,000
Revenue For POCD 25% 1,500,000 3,000,000 6,000,000 9,000,000 12,000,000
COST TOTAL 106,500,000 14,000,000 20,500,000 30,200,000 28,025,000
Labor 500,000 1,000,000 1,500,000 2,200,000 3,025,000
Manufacture&Components 6,000,000 12,000,000 18,000,000 27,000,000 24,000,000
R&D 100,000,000 1,000,000 1,000,000 1,000,000 1,000,000
Operating Profit -105,000,000 -11,000,000 -14,500,000 -21,200,000 -16,025,000
0
20000000
40000000
60000000
80000000
100000000
120000000
140000000
2012 2013 2014 2015 2016 2017 2018 2019 2020
FAMILY COVERED
128,000,000
32,971,097
-120 000 000
-100 000 000
-80 000 000
-60 000 000
-40 000 000
-20 000 000
0
20 000 000
40 000 000
2012 2013 2014 2015 2016 2017 2018 2019 2020
Operating Profit
Operating Profit